Horacio Astudillo de la Vega, CEO de Nanopharmacia Group, es un especialista en medicina genómica y molecular que ha dedicado años de estudio a la “medicina de precisión”, analizando las células de pacientes con cáncer para determinar tratamientos personalizados a través de la nanotecnología.

Currently, cases of breast cancer are increasing exponentially, and our country has not been spared from its incidence. One of the main concerns of experts is that the majority of people diagnosed with this condition seek an oncologist when the tumor is already advanced, complicating the treatment. In this article,...  Read more